{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:03:31Z","timestamp":1789945411500,"version":"4.0.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Acquired radioresistance limits effective radiotherapy. Cuproptosis is a copper-dependent form of cell death driven by mitochondrial copper accumulation and lipoylated protein aggregation. Building on evidence that radioresistant cancer cells exhibit increased cuproptosis susceptibility, here we combine a radiation-responsive, copper-incorporated covalent organic framework (COF\u2011Tpy\u2011Se\u2011Cu) with an oncolytic adenovirus to target this vulnerability. X-ray irradiation triggers copper release from COF\u2011Tpy\u2011Se\u2011Cu and induces FDX1-dependent cuproptosis, while the oncolytic adenovirus depletes intracellular glutathione and stabilizes FDX1 by limiting its mitochondrial protease-mediated degradation. The combination enhances tumor cell death and remodels the immunosuppressive tumor microenvironment into a T-cell-inflamed state. In models of radioresistant tumors in female mice, this regimen improves tumor control and elicits CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell-dependent systemic antitumor immunity and durable immunological memory. These findings support the combined use of radiation-responsive copper delivery and oncolytic virotherapy as a strategy for exploiting cuproptosis susceptibility and improving radiotherapy responses.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-76947-w","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:56:02Z","timestamp":1787327762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A cuproptosis-inducing covalent organic framework synergizes with oncolytic virus for tumor radiotherapy"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9341-2626","authenticated-orcid":false,"given":"Yuan-Tong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Shan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ying","family":"Bie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Qi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Shan","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Bo","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2564-4666","authenticated-orcid":false,"given":"Xing-Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5960-8913","authenticated-orcid":false,"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9722-3264","authenticated-orcid":false,"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"76947_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H. & Jemal, A. Cancer statistics, 2025. CA Cancer J. Clin. 75, 10\u201345 (2025).","journal-title":"CA Cancer J. Clin."},{"key":"76947_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"76947_CR3","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41571-022-00652-y","volume":"19","author":"L Bodei","year":"2022","unstructured":"Bodei, L., Herrmann, K., Sch\u00f6der, H., Scott, A. M. & Lewis, J. S. Radiotheranostics in oncology: current challenges and emerging opportunities. Nat. Rev. Clin. Oncol. 19, 534\u2013550 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"76947_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41571-021-00579-w","volume":"19","author":"G Petroni","year":"2022","unstructured":"Petroni, G., Cantley, L. C., Santambrogio, L., Formenti, S. C. & Galluzzi, L. Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer. Nat. Rev. Clin. Oncol. 19, 114\u2013131 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"76947_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01839-2","volume":"22","author":"L An","year":"2023","unstructured":"An, L., Li, M. & Jia, Q. Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma. Mol. Cancer 22, 140 (2023).","journal-title":"Mol. Cancer"},{"key":"76947_CR6","doi-asserted-by":"publisher","first-page":"e620","DOI":"10.1016\/S1470-2045(14)70345-6","volume":"15","author":"D De Ruysscher","year":"2014","unstructured":"De Ruysscher, D., Faivre-Finn, C., Le Pechoux, C., Peeters, S. & Belderbos, J. High-dose re-irradiation following radical radiotherapy for non-small-cell lung cancer. Lancet Oncol. 15, e620\u2013e624 (2014).","journal-title":"Lancet Oncol."},{"key":"76947_CR7","doi-asserted-by":"publisher","first-page":"103655","DOI":"10.1016\/j.critrevonc.2022.103655","volume":"174","author":"A Beddok","year":"2022","unstructured":"Beddok, A. et al. Clinical and technical challenges of cancer reirradiation: Words of wisdom. Crit. Rev. Oncol. Hematol. 174, 103655 (2022).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"76947_CR8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S0140-6736(24)02319-5","volume":"405","author":"II Verginadis","year":"2025","unstructured":"Verginadis, I. I. et al. Radiotherapy toxicities: mechanisms, management, and future directions. Lancet 405, 338\u2013352 (2025).","journal-title":"Lancet"},{"key":"76947_CR9","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.ccell.2025.03.031","volume":"43","author":"G Lei","year":"2025","unstructured":"Lei, G. et al. Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance. Cancer Cell 43, 1076\u201392.e5 (2025).","journal-title":"Cancer Cell"},{"key":"76947_CR10","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/s41565-024-01784-1","volume":"19","author":"Y Liao","year":"2024","unstructured":"Liao, Y. et al. A cuproptosis nanocapsule for cancer radiotherapy. Nat. Nanotechnol. 19, 1892\u20131902 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"76947_CR11","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov, P. et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375, 1254\u20131261 (2022).","journal-title":"Science"},{"key":"76947_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2025.10.028","volume":"189","author":"AC Lewis","year":"2026","unstructured":"Lewis, A. C. et al. Inhibition of heme biosynthesis triggers cuproptosis in acute myeloid leukemia. Cell 189, 215\u201332.e24 (2026).","journal-title":"Cell"},{"key":"76947_CR13","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s41418-024-01341-2","volume":"31","author":"YT Liu","year":"2024","unstructured":"Liu, Y. T. et al. Dysregulated Wnt\/\u03b2-catenin signaling confers resistance to cuproptosis in cancer cells. Cell Death Differ. 31, 1452\u20131466 (2024).","journal-title":"Cell Death Differ."},{"key":"76947_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41392-025-02192-0","volume":"10","author":"Z Guo","year":"2025","unstructured":"Guo, Z. et al. The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer. Signal Transduct. Target Ther. 10, 149 (2025).","journal-title":"Signal Transduct. Target Ther."},{"key":"76947_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41568-025-00879-8","volume":"26","author":"C Mao","year":"2026","unstructured":"Mao, C., Jiang, D., Koong, A. C. & Gan, B. Exploiting metabolic cell death for cancer therapy. Nat. Rev. Cancer 26, 27\u201345 (2026).","journal-title":"Nat. Rev. Cancer"},{"key":"76947_CR16","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1093\/eurheartj\/ehaf130","volume":"46","author":"B Tu","year":"2025","unstructured":"Tu, B. et al. SLC31A1 loss depletes mitochondrial copper and promotes cardiac fibrosis. Eur. Heart J. 46, 2458\u20132474 (2025).","journal-title":"Eur. Heart J."},{"key":"76947_CR17","doi-asserted-by":"publisher","first-page":"6282","DOI":"10.1039\/D5CS00083A","volume":"54","author":"L Mao","year":"2025","unstructured":"Mao, L. et al. Cuproptosis: mechanisms and nanotherapeutic strategies in cancer and beyond. Chem. Soc. Rev. 54, 6282\u20136334 (2025).","journal-title":"Chem. Soc. Rev."},{"key":"76947_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54469-7","volume":"15","author":"M Guan","year":"2024","unstructured":"Guan, M. et al. Regulating copper homeostasis of tumor cells to promote cuproptosis for enhancing breast cancer immunotherapy. Nat. Commun. 15, 10060 (2024).","journal-title":"Nat. Commun."},{"key":"76947_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202411609","volume":"63","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Near-Infrared activatable copper nanoplatforms synergize with the 5-azacytidine prodrug to potentiate cuproptosis. Angew. Chem. Int. Ed. Engl. 63, e202411609 (2024).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"76947_CR20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41571-024-00876-0","volume":"21","author":"D Tang","year":"2024","unstructured":"Tang, D., Kroemer, G. & Kang, R. Targeting cuproplasia and cuproptosis in cancer. Nat. Rev. Clin. Oncol. 21, 370\u2013388 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"76947_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202417795","volume":"12","author":"X Lin","year":"2025","unstructured":"Lin, X. et al. Targeting intratumoral copper inhibits tumor progression via p62-mediated EZH2 degradation and potentiates anti-PD-1 immunotherapy in oral squamous cell carcinoma. Adv. Sci. 12, e17795 (2025).","journal-title":"Adv. Sci."},{"key":"76947_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","volume":"20","author":"SZ Shalhout","year":"2023","unstructured":"Shalhout, S. Z., Miller, D. M., Emerick, K. S. & Kaufman, H. L. Therapy with oncolytic viruses: progress and challenges. Nat. Rev. Clin. Oncol. 20, 160\u2013177 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"76947_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02477-6","volume":"24","author":"YT Liu","year":"2025","unstructured":"Liu, Y. T. et al. Turning cold tumors into hot tumors to ignite immunotherapy. Mol. Cancer 24, 254 (2025).","journal-title":"Mol. Cancer"},{"key":"76947_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202209379","volume":"35","author":"W Su","year":"2023","unstructured":"Su, W. et al. A dual-responsive STAT3 inhibitor nanoprodrug combined with oncolytic virus elicits synergistic antitumor immune responses by igniting pyroptosis. Adv. Mater. 35, e2209379 (2023).","journal-title":"Adv. Mater."},{"key":"76947_CR25","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S0140-6736(25)01206-1","volume":"406","author":"E Appleton","year":"2025","unstructured":"Appleton, E., Chiocca, E. A., Ungerechts, G., Melcher, A. & Vile, R. Oncolytic viruses as anticancer agents: clinical progress and remaining challenges. Lancet 406, 1295\u20131312 (2025).","journal-title":"Lancet"},{"key":"76947_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48032-7","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Fn-OMV potentiates ZBP1-mediated PANoptosis triggered by oncolytic HSV-1 to fuel antitumor immunity. Nat. Commun. 15, 3669 (2024).","journal-title":"Nat. Commun."},{"key":"76947_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.omto.2022.10.001","volume":"27","author":"S Gohara","year":"2022","unstructured":"Gohara, S. et al. An oncolytic virus as a promising candidate for the treatment of radioresistant oral squamous cell carcinoma. Mol. Ther. Oncolytics 27, 141\u2013156 (2022).","journal-title":"Mol. Ther. Oncolytics"},{"key":"76947_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70202","volume":"6","author":"Y Zhao","year":"2025","unstructured":"Zhao, Y. et al. Targeting the enhanced sensitivity of radiotherapy in cancer: mechanisms, applications, and challenges. MedComm 6, e70202 (2025).","journal-title":"MedComm"},{"key":"76947_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55430-4","volume":"16","author":"L Zhang","year":"2025","unstructured":"Zhang, L. et al. Trigger inducible tertiary lymphoid structure formation using covalent organic frameworks for cancer immunotherapy. Nat. Commun. 16, 44 (2025).","journal-title":"Nat. Commun."},{"key":"76947_CR30","doi-asserted-by":"publisher","first-page":"17689","DOI":"10.1021\/jacs.3c04027","volume":"145","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Activation of pyroptosis using AIEgen-Based sp(2) carbon-linked covalent organic frameworks. J. Am. Chem. Soc. 145, 17689\u201317699 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"76947_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41121-z","volume":"14","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy. Nat. Commun. 14, 5355 (2023).","journal-title":"Nat. Commun."},{"key":"76947_CR32","doi-asserted-by":"publisher","first-page":"116933","DOI":"10.1016\/j.celrep.2026.116933","volume":"45","author":"C Feng","year":"2026","unstructured":"Feng, C. et al. METTL3\/CD98-mediated glutamate efflux in CAFs drives CD8(+) T cell exhaustion and impedes neoadjuvant immunochemotherapy. Cell Rep. 45, 116933 (2026).","journal-title":"Cell Rep."},{"key":"76947_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27485-0","volume":"12","author":"H Li","year":"2021","unstructured":"Li, H. et al. Theranostic near-infrared-IIb emitting nanoprobes for promoting immunogenic radiotherapy and abscopal effects against cancer metastasis. Nat. Commun. 12, 7149 (2021).","journal-title":"Nat. Commun."},{"key":"76947_CR34","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41586-025-09370-8","volume":"646","author":"EN Baruch","year":"2025","unstructured":"Baruch, E. N. et al. Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy. Nature 646, 462\u2013473 (2025).","journal-title":"Nature"},{"key":"76947_CR35","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cmet.2022.08.007","volume":"34","author":"Z Lu","year":"2022","unstructured":"Lu, Z. et al. ATF3 and CH25H regulate effector trogocytosis and anti-tumor activities of endogenous and immunotherapeutic cytotoxic T lymphocytes. Cell Metab. 34, 1342\u20131358.e7 (2022).","journal-title":"Cell Metab."},{"key":"76947_CR36","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41418-019-0380-z","volume":"27","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. ATF3 promotes erastin-induced ferroptosis by suppressing system Xc. Cell Death Differ. 27, 662\u2013675 (2020).","journal-title":"Cell Death Differ."},{"key":"76947_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202413002","volume":"37","author":"L Zhang","year":"2025","unstructured":"Zhang, L. et al. Radioactive diselenide bonded covalent organic framework. Adv. Mater. 37, e2413002 (2025).","journal-title":"Adv. Mater."},{"key":"76947_CR38","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1038\/s41557-025-01974-x","volume":"17","author":"L Zhang","year":"2025","unstructured":"Zhang, L. et al. Discovery of highly fluorescent covalent organic frameworks through AI-assisted iterative experiment-learning cycles. Nat. Chem. 17, 1645\u20131654 (2025).","journal-title":"Nat. Chem."},{"key":"76947_CR39","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","volume":"31","author":"JJ Loh","year":"2024","unstructured":"Loh, J. J. & Ma, S. Hallmarks of cancer stemness. Cell Stem Cell 31, 617\u2013639 (2024).","journal-title":"Cell Stem Cell"},{"key":"76947_CR40","doi-asserted-by":"publisher","first-page":"714","DOI":"10.7150\/thno.88057","volume":"14","author":"I Gorodetska","year":"2024","unstructured":"Gorodetska, I. et al. ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription. Theranostics 14, 714\u2013737 (2024).","journal-title":"Theranostics"},{"key":"76947_CR41","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.cmet.2024.07.011","volume":"36","author":"G Li","year":"2024","unstructured":"Li, G. et al. Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma. Cell Metab. 36, 1696\u2013710.e10 (2024).","journal-title":"Cell Metab."},{"key":"76947_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44576-2","volume":"15","author":"W Dai","year":"2024","unstructured":"Dai, W. et al. Overcoming therapeutic resistance in oncolytic herpes virotherapy by targeting IGF2BP3-induced NETosis in malignant glioma. Nat. Commun. 15, 131 (2024).","journal-title":"Nat. Commun."},{"key":"76947_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35917-2","volume":"14","author":"J Lin","year":"2023","unstructured":"Lin, J. et al. Oncolytic parapoxvirus induces Gasdermin E-mediated pyroptosis and activates antitumor immunity. Nat. Commun. 14, 224 (2023).","journal-title":"Nat. Commun."},{"key":"76947_CR44","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01897-23","volume":"98","author":"Y Sun","year":"2024","unstructured":"Sun, Y. et al. Oncolytic newcastle disease virus induced degradation of YAP through E3 ubiquitin ligase PRKN to exacerbate ferroptosis in tumor cells. J. Virol. 98, e0189723 (2024).","journal-title":"J. Virol."},{"key":"76947_CR45","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1126\/science.adf4154","volume":"382","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Autoregulatory control of mitochondrial glutathione homeostasis. Science 382, 820\u2013828 (2023).","journal-title":"Science"},{"key":"76947_CR46","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41568-025-00903-x","volume":"26","author":"LB Darragh","year":"2026","unstructured":"Darragh, L. B. & Karam, S. D. Radiation as an immune modulator: mechanisms and implications for combination with immunotherapy. Nat. Rev. Cancer 26, 270\u2013284 (2026).","journal-title":"Nat. Rev. Cancer"},{"key":"76947_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201907568","volume":"32","author":"S Gao","year":"2020","unstructured":"Gao, S. et al. Selenium-containing nanoparticles combine the nk cells mediated immunotherapy with radiotherapy and chemotherapy. Adv. Mater. 32, e1907568 (2020).","journal-title":"Adv. Mater."},{"key":"76947_CR48","doi-asserted-by":"publisher","unstructured":"Lei, G. et al. Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistance. Cell. https:\/\/doi.org\/10.1016\/j.cell.2026.05.036 (2026).","DOI":"10.1016\/j.cell.2026.05.036"},{"key":"76947_CR49","doi-asserted-by":"publisher","first-page":"2096362","DOI":"10.1080\/2162402X.2022.2096362","volume":"11","author":"Q Wang","year":"2022","unstructured":"Wang, Q. et al. Oncolytic adenovirus with MUC16-BiTE shows enhanced antitumor immune response by reversing the tumor microenvironment in PDX model of ovarian cancer. Oncoimmunology 11, 2096362 (2022).","journal-title":"Oncoimmunology"},{"key":"76947_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202103470","volume":"9","author":"L Ding","year":"2022","unstructured":"Ding, L. et al. An inter-supplementary biohybrid system based on natural killer cells for the combinational immunotherapy and virotherapy of cancer. Adv. Sci. 9, e2103470 (2022).","journal-title":"Adv. Sci."},{"key":"76947_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30303-w","volume":"13","author":"YL Wang","year":"2022","unstructured":"Wang, Y. L. et al. MRNIP condensates promote DNA double-strand break sensing and end resection. Nat. Commun. 13, 2638 (2022).","journal-title":"Nat. Commun."},{"key":"76947_CR52","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s43657-020-00008-5","volume":"1","author":"G Zhang","year":"2021","unstructured":"Zhang, G., Zhang, Y. & Jin, J. The ultrafast and accurate mapping algorithm FANSe3: mapping a human whole-genome sequencing dataset within 30 minutes. Phenomics 1, 22\u201330 (2021).","journal-title":"Phenomics"},{"key":"76947_CR53","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41556-024-01419-6","volume":"26","author":"H Liu","year":"2024","unstructured":"Liu, H. et al. TFAM is an autophagy receptor that limits inflammation by binding to cytoplasmic mitochondrial DNA. Nat. Cell Biol. 26, 878\u2013891 (2024).","journal-title":"Nat. Cell Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76947-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76947-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76947-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:55:20Z","timestamp":1789944920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76947-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76947"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76947-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10011"}}